Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Desmond Choy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Elife|September 6, 2024
ImmCellTyper facilitates systematic mass cytometry data analysis for deep immune profilingJing Sun, Desmond Choy, Nicolas Sompairac, et al.
Molecular Therapy Oncolytics|December 11, 2023
Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy productsCharlotte O'Brien Gore, Amy Billman, Suchete Hunjan, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 11, 2024
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanismsNahid Zareian, Oleg Eremin, Hardev Pandha, et al.
Developmental Cell|July 13, 2023
LYVE-1<sup>+</sup> macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancerJoanne E Anstee, Karen T Feehan, James W Opzoomer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Elife|September 6, 2024
ImmCellTyper facilitates systematic mass cytometry data analysis for deep immune profilingJing Sun, Desmond Choy, Nicolas Sompairac, et al.
Molecular Therapy Oncolytics|December 11, 2023
Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy productsCharlotte O'Brien Gore, Amy Billman, Suchete Hunjan, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 11, 2024
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanismsNahid Zareian, Oleg Eremin, Hardev Pandha, et al.
Developmental Cell|July 13, 2023
LYVE-1<sup>+</sup> macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancerJoanne E Anstee, Karen T Feehan, James W Opzoomer, et al.
Pageof 1